Sorafenib KiNativ -- dose response experiment - Dataset (ID:20087)
Proteins Studied
Download: Excel (XLSX), Comma-separated (CSV)
| LINCS ID | Name | HMS LINCS ID | UniProt ID | Alternative Names | Provider | Mutation | Phosphlorylation State | Domain | Protein Description |
|---|---|---|---|---|---|---|---|---|---|
| 200830 | SMG1 | 200830 | Q96Q15 | Serine/threonine-protein kinase SMG1 | KiNativ | ||||
| 200652 | CaMKK2 | 200652 | Q96RR4 | Calcium/calmodulin-dependent protein kinase kinase 2 | KiNativ | ||||
| 200825 | RSKL1_domain1 | 200825 | Q96S38 | Ribosomal protein S6 kinase delta-1 | KiNativ | domain1 | |||
| 200812 | PRPK | 200812 | Q96S44 | TP53-regulating kinase | KiNativ | ||||
| 200735 | MAP3K5,MAP3K6,MAP3K7 | 200735 | Q99683 | Mitogen-activated protein kinase kinase kinase 5 | KiNativ | ||||
| 200733 | MAP3K3 | 200733 | Q99759 | Mitogen-activated protein kinase kinase kinase 3 | KiNativ | ||||
| 200806 | PKD2 | 200806 | Q9BZL6 | Protein kinase D2 | KiNativ | ||||
| 200827 | SLK | 200827 | Q9H2G2 | STE20-like serine/threonine-protein kinase; CTCL tumor antigen se20-9; bA16H23.1; KIAA0204; LOSK; MGC133067; se20-9; SLK; STK2 | KiNativ | ||||
| 200829 | SLK | 200829 | Q9H2G2 | STE20-like serine/threonine-protein kinase; CTCL tumor antigen se20-9; bA16H23.1; KIAA0204; LOSK; MGC133067; se20-9; SLK; STK2 | KiNativ | ||||
| 200828 | SLK | 200828 | Q9H2G2 | STE20-like serine/threonine-protein kinase; CTCL tumor antigen se20-9; bA16H23.1; KIAA0204; LOSK; MGC133067; se20-9; SLK; STK2 | KiNativ | ||||
| 200834 | TAO1,TAOK3 | 200834 | Q9H2K8 | Serine/threonine-protein kinase TAO3; TAO kinase 3; DKFZp666H245; DPK; FLJ31808; JIK; MAP3K18; TAO3 | KiNativ | ||||
| 200768 | NEK6,NEK7 | 200768 | Q9HC98 | Serine/threonine-protein kinase Nek6 | KiNativ | ||||
| 200701 | IRAK4 | 200701 | Q9NWZ3 | Interleukin-1 receptor-associated kinase 4; IPD1; NY-REN-64; REN64 | KiNativ | ||||
| 200845 | MLTK | 200845 | Q9NYL2 | Mitogen-activated protein kinase kinase kinase MLT; sterile alpha motif and leucine zipper containing kinase AZK; AZK; MLK7; mlklak; MLT; MLTK; MRK; pk; ZAK | KiNativ | ||||
| 200737 | MARK1 | 200737 | Q9P0L2 | Serine/threonine-protein kinase MARK1 | KiNativ | ||||
| 200692 | GCN2_domain2 | 200692 | Q9P2K8 | Eukaryotic translation initiation factor 2-alpha kinase 4 | KiNativ | domain2 | |||
| 200691 | GCN2_domain2 | 200691 | Q9P2K8 | Eukaryotic translation initiation factor 2-alpha kinase 4 | KiNativ | domain2 | |||
| 200791 | PI4KB | 200791 | Q9UBF8 | Phosphatidylinositol 4-kinase beta | KiNativ | ||||
| 200790 | PI4KB | 200790 | Q9UBF8 | Phosphatidylinositol 4-kinase beta | KiNativ | ||||
| 200781 | KS6B2 | 200781 | Q9UBS0 | Ribosomal protein S6 kinase beta-2 | KiNativ | ||||
| 200782 | KS6B2 | 200782 | Q9UBS0 | Ribosomal protein S6 kinase beta-2 | KiNativ | ||||
| 200836 | TBK1 | 200836 | Q9UHD2 | Serine/threonine-protein kinase TBK1; TANK-binding kinase 1; NF-kappa-B-activating kinase; FLJ11330; NAK; T2K; TBK1 | KiNativ | ||||
| 200849 | ZC2/TNIK,ZC3/MINK | 200849 | Q9UKE5 | TRAF2 and NCK-interacting kinase | KiNativ | ||||
| 200848 | ZC2/TNIK | 200848 | Q9UKE5 | TRAF2 and NCK-interacting kinase | KiNativ | ||||
| 200837 | TLK1 | 200837 | Q9UKI8 | Serine/threonine-protein kinase tousled-like 1; tousled-like kinase 1; KIAA0137; PKU-beta; TLK1 | KiNativ |